Oral Clofarabine Study in Patients With Myelodysplastic Syndrome

Clinical trial NCT00299156 · COMPLETED

Trial details

NCT number: NCT00299156
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia

Start date: 2006-03-01
Primary completion: 2012-12-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.